NCT04567446

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,100 (estimated)
• Sponsor: Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Multicentric prospective study with collection of biological samples as part of type II research

Conditions

• Cancer

Interventions

Type	Name	Description
OTHER	Stool	collection at baseline (or before the third injection), at the first evaluation (CT-scan), at ≥ 6 months after the first injection, at toxicity and at relapse, at 1 week after the end of antibiotics treatment
OTHER	Blood sample	20 mL collection at baseline (or before the third injection), at the first evaluation (CT-scan), at ≥ 6 months after the first injection, at toxicity and at relapse, at 1 week after the end of antibiotics treatment

Timeline

• Start date: 2018-01-22
• Primary completion: 2024-12-01
• Completion: 2024-12-01
• First posted: 2020-09-28
• Last updated: 2024-06-12

Locations

9 sites across 1 country: France